| OMIC |
Singular Genomics Systems, Inc. |
Common Stock, par value $0.0001 per share |
100% |
$20,010 |
-$4,972,385 |
1,000 |
-100% |
Deerfield Mgmt IV, L.P. |
21 Feb 2025 |
| LRMR |
Larimar Therapeutics, Inc. |
Common Stock, par value $0.0001 per share |
36% |
$82,495,505 |
|
30,667,474 |
|
Deerfield Management Company, L.P. |
31 Jul 2025 |
| NUVL |
Nuvalent, Inc. |
Class A common stock, $0.0001 par value per share |
28% |
$1,563,269,209 |
|
23,582,278 |
|
Deerfield Management Company, L.P. |
31 Dec 2024 |
| PHGE |
BiomX Inc. |
Common Stock, par value $0.0001 per share |
10% |
$11,359,221 |
|
15,558,445 |
|
Deerfield Management Company, L.P. |
27 Feb 2025 |
| AFIB |
Acutus Medical, Inc. |
Common Stock, par value $0.001 per share |
9.1% |
$233,441 |
-$179,058 |
5,492,725 |
-43% |
James E. Flynn |
27 Jan 2025 |
| AHCO |
AdaptHealth Corp. |
Class A Common Stock |
8.5% |
$213,579,981 |
|
23,863,685 |
|
Deerfield Management Company, L.P. |
30 Sep 2025 |
|
Lomond Therapeutics Holdings, Inc. |
Common Stock |
8.4% |
|
|
2,692,625 |
|
Deerfield Mgmt, L.P. |
30 Sep 2025 |
| SPRY |
ARS Pharmaceuticals, Inc. |
Common Stock, par value $0.0001 per share |
7.8% |
$101,139,784 |
-$13,599,923 |
7,610,217 |
-12% |
Deerfield Management Company, L.P. |
30 Jul 2025 |
| SVRA |
Savara Inc. |
Common Stock |
6.7% |
$48,441,330 |
|
13,569,000 |
|
Deerfield Mgmt, L.P. |
30 Oct 2025 |
| COGT |
Cogent Biosciences, Inc. |
Common Stock |
6.5% |
$46,442,495 |
|
9,053,118 |
|
Deerfield Mgmt, L.P. |
07 Jul 2025 |
| BBOT |
BridgeBio Oncology Therapeutics, Inc. |
Common Stock |
6.2% |
$46,167,465 |
|
4,885,446 |
|
Deerfield Management Company, L.P. |
11 Aug 2025 |
| BCRX |
BioCryst Pharmaceuticals, Inc. |
Common Stock |
5.8% |
$103,071,430 |
|
12,169,000 |
|
Deerfield Mgmt, L.P. |
12 Sep 2025 |
| VERA |
Vera Therapeutics, Inc. |
Common Stock |
5.2% |
$75,299,151 |
|
3,348,117 |
|
Deerfield Mgmt, L.P. |
06 Jun 2025 |
| INSP |
Inspire Medical Systems, Inc. |
Common Stock |
5.1% |
$109,541,683 |
|
1,476,303 |
|
Deerfield Mgmt, L.P. |
06 Nov 2025 |
| CGEM |
Cullinan Therapeutics, Inc. |
Common Stock |
5% |
$17,357,187 |
|
2,927,013 |
|
Deerfield Mgmt, L.P. |
30 Sep 2025 |
| DCGO |
DocGo Inc. |
Common Stock |
5% |
$13,335,960 |
|
5,051,500 |
|
Deerfield Mgmt, L.P. |
13 Feb 2025 |
| CERT |
Certara, Inc. |
Common Stock |
4.9% |
$88,705,753 |
-$25,019,207 |
7,808,605 |
-22% |
Deerfield Mgmt, L.P. |
25 Nov 2025 |
| BKD |
Brookdale Senior Living Inc. |
Common Stock |
4.9% |
$85,415,815 |
-$27,343,203 |
11,637,032 |
-24% |
Deerfield Mgmt, L.P. |
22 Aug 2025 |
| EMBC |
Embecta Corp. |
Common Stock |
4.7% |
$33,462,580 |
|
2,720,535 |
|
Deerfield Mgmt, L.P. |
31 Mar 2025 |
| MNKTQ |
Mallinckrodt plc |
Ordinary Shares, par value $0.01 per share |
4.1% |
|
|
804,259 |
|
Deerfield Management Company, L.P. |
31 Mar 2025 |
| ALHC |
Alignment Healthcare, Inc. |
Common Stock |
3.8% |
$144,479,094 |
|
7,304,302 |
|
Deerfield Mgmt, L.P. |
31 Dec 2024 |
| INDV |
Indivior PLC |
Ordinary Shares, $0.50 nominal value per share |
3.7% |
$111,255,547 |
-$143,518,681 |
4,614,498 |
-56% |
Deerfield Mgmt, L.P. |
10 Nov 2025 |
| CPRX |
Catalyst Pharmaceuticals, Inc. |
Common Stock |
2.6% |
$75,975,517 |
|
3,133,011 |
|
Deerfield Mgmt, L.P. |
31 Dec 2024 |
| VTYX |
Ventyx Biosciences, Inc. |
Common Stock |
0.76% |
$502,653 |
|
534,737 |
|
Deerfield Mgmt, L.P. |
31 Dec 2024 |
| KURA |
Kura Oncology, Inc. |
Common Stock |
0% |
$0 |
|
0 |
|
Deerfield Mgmt, L.P. |
31 Dec 2024 |
| OMI |
Owens & Minor, Inc. |
Common Stock |
0% |
$0 |
|
0 |
|
Deerfield Mgmt, L.P. |
31 Mar 2025 |
| PRLD |
Prelude Therapeutics Incorporated |
Common Stock |
0% |
$0 |
|
0 |
|
Deerfield Mgmt, L.P. |
31 Dec 2024 |
| OSCR |
Oscar Health, Inc. |
Class A Common Stock |
0% |
$0 |
|
0 |
|
Deerfield Mgmt, L.P. |
30 Sep 2025 |